ConductScience.org, home

Paper25754814

Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity.

Lauber K and 6 others. Cancer Lett, 2015. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity. Papers, record 25754814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25754814

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity.
PubMed
Journal
Cancer Lett
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2015-09-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lauber KKirsten
2Brix NNikko
3Ernst AAnne
4Hennel RRoman
5Krombach JJulia
6Anders HHeike
7Belka CClaus

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HSP90 Heat-Shock ProteinsMajor topic
Heat-Shock ResponseMajor topic
Hyperthermia, InducedMajor topic
NeoplasmsMajor topic
Animals
Cell Death
Combined Modality Therapy
Heat-Shock Proteins
Humans

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
41375025Temperature-Dependent Effects of Induced Hyperthermia, Including Whole-Body Hyperthermia, on the Hallmarks of Cancer: A Systematic Review.Cancers (Basel)2025https://conductscience.org/library/papers/41375025PubMed
41269528Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses.EJNMMI Res2025https://conductscience.org/library/papers/41269528PubMed
39416669Multifunctional gold nanoparticles for cancer theranostics.3 Biotech2024https://conductscience.org/library/papers/39416669PubMed
38067348Efficient Radial-Shell Model for 3D Tumor Spheroid Dynamics with Radiotherapy.Cancers (Basel)2023https://conductscience.org/library/papers/38067348PubMed
37986165
Machine learning-based analysis of cancer cell-derived vesicular proteins revealed significant tumor-specificity and predictive potential of extracellular vesicles for cell invasion and proliferation - A meta-analysis.
Cell Commun Signal2023https://conductscience.org/library/papers/37986165PubMed
37794000Myoglobin-loaded gadolinium nanotexaphyrins for oxygen synergy and imaging-guided radiosensitization therapy.Nat Commun2023https://conductscience.org/library/papers/37794000PubMed
36422293Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration.Metabolites2022https://conductscience.org/library/papers/36422293PubMed
35043518HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.Cancer Sci2022https://conductscience.org/library/papers/35043518PubMed
34986545Abscopal effect in the radio and immunotherapy.Radiat Oncol J2021https://conductscience.org/library/papers/34986545PubMed
33816244Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.Front Oncol2021https://conductscience.org/library/papers/33816244PubMed
33053689Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.Int J Mol Sci2020https://conductscience.org/library/papers/33053689PubMed
33005832The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure.Bioact Mater2021https://conductscience.org/library/papers/33005832PubMed
32984042Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90.Front Oncol2020https://conductscience.org/library/papers/32984042PubMed
32640548Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.Int J Mol Sci2020https://conductscience.org/library/papers/32640548PubMed
32340275Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death.Cancers (Basel)2020https://conductscience.org/library/papers/32340275PubMed
32099495Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: Emerging Mechanisms and Perspectives.Lung Cancer (Auckl)2019https://conductscience.org/library/papers/32099495PubMed
320153963D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments.Sci Rep2020https://conductscience.org/library/papers/32015396PubMed
31776398A cellular automaton model for spheroid response to radiation and hyperthermia treatments.Sci Rep2019https://conductscience.org/library/papers/31776398PubMed
31540530Cellular Stress Responses in Radiotherapy.Cells2019https://conductscience.org/library/papers/31540530PubMed
31500898Focused Ultrasound-Mediated Hyperthermia in Vitro: An Experimental Arrangement for Treating Cells under Tissue-Mimicking Conditions.Ultrasound Med Biol2019https://conductscience.org/library/papers/31500898PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25754814

GET https://conductscience.org/api/papers/v1/25754814/cited_by?page=2